Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1377 of 5804
-
New shot could tame severe hay fever symptoms
Symptom relief Recruiting nowAllergic rhinitis (AR) is a non-infectious chronic inflammatory disease of the nasal mucosa mainly mediated by immunoglobulin E after exposure to allergens in atopic individuals. The typical symptoms of AR are paroxysmal sneezing, watery rhinorrhea, itching, and nasal congestion,…
Phase: PHASE2 • Sponsor: Beijing Tongren Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Gout drug study aims for fewer infusions, same relief
Disease control CompletedThe study consists of 24-week double-blind trial to evaluate the non-inferiority of the efficacy and safety of pegloticase Q4W with MTX versus pegloticase Q2W with MTX, followed by a 24-week open-label extension of pegloticase Q4W with MTX, in participants with uncontrolled refra…
Phase: PHASE4 • Sponsor: Amgen • Aim: Disease control
Last updated Jul 03, 2026 00:00 UTC
-
Van clinic delivers lifesaving prevention to women at high risk
Prevention CompletedThe investigators will implement a non-randomized observational clinical trial that will include a pop-up clinic for women who inject drugs (WWID) near venues for exchange sex and drug use in north Seattle. The pop-up clinic will be housed within a van and serve as a research ext…
Phase: NA • Sponsor: University of Washington • Aim: Prevention
Last updated Jun 27, 2026 09:07 UTC
-
New weekly shot shows promise for diabetes and weight loss
Disease control CompletedThis study will look at how well a new medicine called NNC0519-0130 helps people with type 2 diabetes lower their blood sugar and body weight. The study will test up to 7 different doses of NNC0519-0130. Which treatment participant will get is decided by chance. Participants will…
Phase: PHASE2 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Could virtual reality ease chronic neck pain?
Symptom relief CompletedThis study aimed to investigate the effect of adding virtual reality therapy to conventional treatment in patients with chronic neck pain on pain, neck disability index, kinesiophobia, insomnia severity questionnaire, hospital anxiety depression scale, cervical range of motion an…
Phase: NA • Sponsor: Kirsehir Ahi Evran Universitesi • Aim: Symptom relief
Last updated Jul 16, 2026 00:00 UTC
-
VR headset games tested as new ADHD therapy for children
Symptom relief Recruiting nowBackground: Children with attention deficit hyperactivity disorder (ADHD) often have cognitive problems. It may be hard for them to control their behaviors, concentrate for long periods, or make decisions. This can affect their education, friendships, and daily life. Virtual rea…
Phase: PHASE1, PHASE2 • Sponsor: National Institute of Mental Health (NIMH) • Aim: Symptom relief
Last updated Jul 12, 2026 00:00 UTC
-
Community leaders step up to boost COVID shots in black rheumatic patients
⭐️ VACCINE ⭐️ OngoingTo establish the efficacy of a community-based POL (Popular Opinion Leader) intervention with two different trainings designed to increase COVID-19 vaccine and booster uptake and reduce hesitancy among social networks of Black individuals with rheumatic conditions. The investigat…
Phase: NA • Sponsor: Northwestern University • Aim: ⭐️ VACCINE ⭐️
Last updated Jun 27, 2026 13:00 UTC
-
Which IV fluid helps DKA patients leave the hospital faster?
Disease control Recruiting nowThe goal of this blinded, cluster cross-over, randomised controlled trial is to determine whether fluid therapy with Plasma-Lyte® 148 increases the number of days alive and days out of hospital to day-28 compared to 0.9% sodium chloride ('0.9% saline') in critically ill patients …
Phase: PHASE3 • Sponsor: The George Institute • Aim: Disease control
Last updated Jun 26, 2026 17:57 UTC
-
Can diet, exercise, and pills tame metabolic syndrome?
Disease control Recruiting nowThis study is a randomized, parallel-group, observer-masked clinical trial. A total of 200 obese participants with MetS will be enrolled. Eligible subjects will be randomly assigned to the ILI group or ULI group with an allocation ratio of 2:1. The ILI group will be instructed to…
Phase: NA • Sponsor: National Health Research Institutes, Taiwan • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New combo therapy shows promise in early sarcoma trial
Disease control OngoingIn this study, patients with soft tissue sarcoma (STS) will receive ADI-PEG 20 and ifosfamide in combination with radiation as neoadjuvant therapy. In phase I of the study, up to 5 dose levels will be tested to find the recommended phase II dose (RP2D), after which patients enrol…
Phase: PHASE1 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 12:10 UTC
-
New radiation schedule could cut treatment time for throat cancer patients
Disease control Recruiting nowTo compare the acute tolerance of highly conformal hypofractionated versus conventional radiotherapy.
Phase: NA • Sponsor: University of Texas Southwestern Medical Center • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
Gut bugs may hold key to stomach cancer treatment success
Knowledge-focused Recruiting nowThis study is designed as a single-center, open-label, phase II exploratory trial. Patients with advanced or locally advanced gastric cancer who have not received chemotherapy or immunotherapy before are eligible for inclusion. They will receive a first-line two-drug combination …
Sponsor: Fudan University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:03 UTC
-
New antibiotic shows promise for newborns with dangerous infections
Disease control CompletedThe primary purpose of this study is to understand the pharmacokinetics (PK) of single and multiple doses of cefiderocol in children from birth to less than 3 months of age with suspected or confirmed aerobic Gram-negative bacterial infections.
Phase: PHASE2 • Sponsor: Shionogi • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Eating within a 10-hour window may shield breast cancer patients from heart-harming fat buildup
Disease control Recruiting nowBackground \& Rationale: Breast cancer (BC) is the most commonly diagnosed malignancy in women worldwide (2.1 million diagnoses in 2018, 25% of new cancer cases). In Canada, early stage BC mortality rates have decreased by 48% over the past 30 years as a result of advances in pr…
Phase: NA • Sponsor: University of Alberta • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Rectal cancer patients may skip surgery with chemo and watchful waiting
Disease control Recruiting nowThis pilot trial studies how well active surveillance and chemotherapy before surgery work in treating participants with stage II-III rectal cancer. Active surveillance involves monitoring participants for additional tumor growth after receiving cancer treatment. Drugs used in ch…
Phase: EARLY_PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:36 UTC
-
CBD could be a safer alternative to opioids after knee surgery
Symptom relief Recruiting nowThe goal of this study is to better understand how daily treatment with cannabidiol (CBD) affects the need for opioid pain medication, as well as pain, inflammation and other related symptoms, after knee replacement surgery. The information collected in this study is necessary to…
Phase: PHASE2 • Sponsor: Chad Brummett • Aim: Symptom relief
Last updated Jun 27, 2026 12:07 UTC
-
Lupus trial tests NAD+ booster to tame immune system
Disease control Recruiting nowStudy Description: Systemic lupus erythematosus (SLE) occurs predominantly in women and is driven by type I interferon dysregulation and neutrophil hyperresponsiveness. Neutrophils in females have reduced mitochondrial bioenergetic capacity which affects immunometabolism. Nicoti…
Phase: PHASE1, PHASE2 • Sponsor: National Heart, Lung, and Blood Institute (NHLBI) • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can 'Meaning Therapy' reduce burnout for cancer caregivers?
Symptom relief Recruiting nowParticipants will complete 1 set of questionnaires about 2 weeks before beginning their Meaning-Centered Psychotherapy for Caregivers/MCP-C or standard Supportive Psychotherapy for Caregivers/SP-C sessions. These questionnaires will ask about participants' sense of meaning and pu…
Phase: NA • Sponsor: Icahn School of Medicine at Mount Sinai • Aim: Symptom relief
Last updated Jun 27, 2026 12:37 UTC
-
Which painkiller causes less nausea in kids after surgery? a head-to-head trial
Symptom relief Recruiting nowPOPCORN trial will compare the side effects and effectiveness of Morphine versus Oxycodone medication when prescribed for use as patient controlled analgesia (PCA) for pain relief for paediatric patients after-surgery. This trial is embedded into routine patient care using the ho…
Phase: PHASE4 • Sponsor: Murdoch Childrens Research Institute • Aim: Symptom relief
Last updated Jul 23, 2026 00:00 UTC
-
New program aims to help HIV/TB patients kick the habit
Symptom relief Recruiting nowThe purpose of this study is to integrate elements from existing interventions developed by our team into a single intervention (QUIT-AD), designed to improve smoking cessation and favorable HIV/TB treatment outcomes among individuals with HIV and/or TB in Cape Town, South Africa…
Phase: NA • Sponsor: Massachusetts General Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC